Exhibition

Urinebased InVitro Cancer Diagnostic Product

Negotiable Others | Min Order Quantity Unit
Required
Quantity
Place of Origin
South Korea
Payment Terms
L/C,T/T,Others
Production
method
Available
Shipping /
Lead Time
Negotiable / Negotiable
Keyword
cancer, device, diagnostic, screening,
Category
Monitoring & Diagnostic Equipment , Health Products , Other Monitoring & Diagnostic Equipment , Other Health Care Products

3 Cube Bio

Supplier Activity

tradeKorea provides seller activity to buyers throu gh seller evaluation and measurement according to each item.

  • Country

    South Korea South Korea

    Product name Urinebased InVitro Cancer Diagnostic Product Certification -
    Category Monitoring & Diagnostic Equipment
    Health Products
    Other Monitoring & Diagnostic Equipment
    Other Health Care Products
    Material -
    Keyword cancer , device , diagnostic , screening Unit Size -
    Brand name - Unit Weigh -
    origin South Korea Stock 999999
    Supply type Available HS code -
    Product Information

     

     

     

     

    It is an in vitro diagnostic product that defines the presence of cancer with urine by early screening. With a single test, you can test for 6 types of cancer and check the results within 20 minutes. 

    Our product is an in vitro diagnostic product that can be easily and quickly examined for cancer at a reasonable price, and it can be collected in a non-invasive way, so it is possible to conduct frequent checkups without side effects or pain.

    Regardless of its expertise, our products can be reached by anyone to test for cancer and be able to expect increase of survival rate by the frequency of the test.

     

     

     

     

     

     

    Early diagnosis is important for cancer. However, many people are delaying cancer screening due to psychological (burden of screening procedures, time burdens, concerns about side effects, etc.) and economic burdens.

     

    Our product is a primary screening analyzer that uses urine specimens to discern the presence of breast, colorectal, stomach, lung, liver, and pancreatic cancer within about 20 minutes.

     

    In the case of conventional cancer screening methods, only professional medical personnel can use it, and it takes 3 to 7 days to have the results. Also, taking a sample is painful and there are concerns about side effects.

     

    Our product is an in-vitro diagnostic device that can be used not only by professional medical personnel, but also by quasi-professional and non-professional medical personnel for cancer screening. It is possible to check the cancer screening results by connecting the device with computers or smartphones, so it can be used in medical institutions and other places such as home and office.

     

    In addition, urine can be collected in a non-invasive way, so it does not involve any side effect or pain which allows frequent checkups.

     

    Our in-vitro diagnostic devices allow anyone to easily and quickly screen for cancer, which can increase people's access to cancer screening and improve early diagnosis rates. And it will contribute to alleviating people's fear of cancer and increasing the cancer survival rate.

     

    B2B Trade
    Price (FOB) Negotiable transportation Ocean Shipping,Air Transportation,Negotiation Other
    MOQ Negotiable Leadtime Negotiable
    Payment Options L/C,T/T,Others Shipping time Negotiable

    3 Cube Bio

    • Country

      South Korea South Korea
    • Supplier Activity

    • President

      Eunjong Choi

    • Address

      Digital-ro 10-gil Geumcheon-gu Seoul, Geumcheon-gu, Seoul, Korea

    • Product Category

      Other Monitoring & Diagnostic Equipment

    • Year Established

      2011

    • No. of Total Employees

      1-50

    • Company introduction

      CUBEBIOis a Korean biomedical company conducting a global business by specializing indeveloping in-vitro diagnostic devices to discern the existence of cancers andepidemic diseases. Our product portfolio ranges from cancer screening deviceusing urine as a specimen to COVID-19 test kits and other healthcare productlines (Sterilizations, Pet diagnosis, Smart childcare, etc)

      Currently,we’re working with Seoul National University Hospital to carry out an internationalproject to universalize the technology around the globe and are discussingparticipation in the project with renowned hospitals from each country. Untilnow, we’re on discussion with high ranked hospitals in 10 different countriesand aiming more than 100 hospitals in 40 different countries to participate inthis project. Furthermore, we’re actively enhancing the opportunity ofcooperation with medical distributors with close relations with prominenthospitals.

    • Main Markets
      • Germany Germany
      • Hong Kong(China) Hong Kong(China)
      • Indonesia Indonesia
      • Saudi Arabia Saudi Arabia
      • U.S.A U.S.A
    • Main Product
      • Urinebased InVitro Cancer Diagnostic Product

        Urinebased InVitro Cancer Diagnostic Product

    • Attached File

      Urine Analyzer_CUBEBIO.pdf

    • Related Products

      Hydrogen Miracle Water WS1212

      Singsing natural apple juice Korean apple 100% 1box 50piece

      Electric ULV Sprayer, Pest control sprayer, ATOMER 2

      Portable Hydrogen Water tumbler BlueWater700M-PEM technology

      Portable Compact hydrogen water tumbler BlueWater 900S

    • TRADE SHOWs "Cheongju EXPO 2022"

      Aluminum powder

      A House of Full Love

      Udo Peanut Traditional Liquor

      Sejong Raspberry Wine

      glutinous nurungji (Embryo-retaining polished rice) / Snacks / SafeFood

    • Other Products viewed with This Product